Cargando…

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study

BACKGROUND: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. AIM: To assess the risk of COVID-19 in healthcare workers with IBD. METHODS: A case control study enrolled 326 healthcar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amiot, Aurelien, Bourrier, Anne, Gornet, Jean-Marc, Dewit, Olivier, Nancey, Stephane, Altwegg, Romain, Abitbol, Vered, Laharie, David, Reenaers, Catherine, Gagnière, Charlotte, Buisson, Anthony, Nachury, Maria, Viennot, Stephanie, Vuitton, Lucine, Stefanescu, Carmen, Marteau, Philippe, Bouguen, Guillaume, Seksik, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800326/ https://www.ncbi.nlm.nih.gov/pubmed/36601289 http://dx.doi.org/10.1016/j.infpip.2022.100267

Ejemplares similares

Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
por: Vuitton, Lucine, et al.
Publicado: (2022)

Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study
por: Chappe, Capucine, et al.
Publicado: (2023)

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
por: Bouhnik, Yoram, et al.
Publicado: (2018)

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Sexual health and fertility for individuals with inflammatory bowel disease
por: Leenhardt, Romain, et al.
Publicado: (2019)

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Rayer, Cassandra, et al.
Publicado: (2023)

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Cassandra, Rayer, et al.
Publicado: (2022)

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)

Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease
por: Le Gall, Guillaume, et al.
Publicado: (2018)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
por: Louis, Edouard, et al.
Publicado: (2023)

Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
por: Lelong, Margaux, et al.
Publicado: (2022)

Factors affecting outcomes in Crohn's disease over 15 years
por: Cosnes, Jacques, et al.
Publicado: (2012)

A plea for the pathogenic role of immune complexes in severe Covid-19
por: Vuitton, Dominique A., et al.
Publicado: (2020)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
por: Altwegg, Romain, et al.
Publicado: (2014)

Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Non-surgical and non-chemical attempts to treat echinococcosis: do they work?
por: Tamarozzi, Francesca, et al.
Publicado: (2014)

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy
por: Scialom, Sophie, et al.
Publicado: (2015)

Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy
por: Poullenot, Florian, et al.
Publicado: (2023)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index
por: Abitbol, Vered, et al.
Publicado: (2015)

Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations
por: Louis, Edouard, et al.
Publicado: (2015)

rs2476601 polymorphism in PTPN22 is associated with Crohn’s disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls
por: Hedjoudje, Abdellah, et al.
Publicado: (2017)

Larval Echinococcus multilocularis infection reduces dextran sulphate sodium‐induced colitis in mice by attenuating T helper type 1/type 17‐mediated immune reactions
por: Wang, Junhua, et al.
Publicado: (2017)

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
por: Sokol, Harry, et al.
Publicado: (2020)

Impact of N-Acyl-Homoserine Lactones, Quorum Sensing Molecules, on Gut Immunity
por: Coquant, Garance, et al.
Publicado: (2020)

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
por: Tran-Minh, My-Linh, et al.
Publicado: (2017)

Layer Morphology and Ink Compatibility of Silver Nanoparticle Inkjet Inks for Near-Infrared Sintering
por: Reenaers, Dieter, et al.
Publicado: (2020)

Use of imaging modalities for decision-making in inflammatory bowel disease
por: Nancey, Stéphane, et al.
Publicado: (2023)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

Evaluation by a Machine Learning System of Two Preparations for Small Bowel Capsule Endoscopy: The BUBS (Burst Unpleasant Bubbles with Simethicone) Study
por: Houdeville, Charles, et al.
Publicado: (2022)

Genetic effects on the commensal microbiota in inflammatory bowel disease patients
por: Aschard, Hugues, et al.
Publicado: (2019)

Navigating adalimumab biosimilars: an expert opinion
por: Abitbol, Vered, et al.
Publicado: (2023)

Development of a computed cleansing score to assess quality of bowel preparation in colon capsule endoscopy
por: Becq, Aymeric, et al.
Publicado: (2018)

Patients’ comorbidities reduce the clinical value of emergency colonoscopy: results of a retrospective cohort study
por: Cremone, Cristiano, et al.
Publicado: (2017)

Development and validation of an automated algorithm to evaluate the abundance of bubbles in small bowel capsule endoscopy
por: Pietri, Olivia, et al.
Publicado: (2018)

Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
por: Le Baut, Guillaume, et al.
Publicado: (2018)

A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease
por: Le Cosquer, Guillaume, et al.
Publicado: (2022)

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases
por: Michaudel, Chloé, et al.
Publicado: (2023)

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases
por: Robbe Masselot, Catherine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q3gkeab4egt7t1ndlg8ol4kcur